These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 15577118)

  • 41. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
    Stracke S; Keller F; Steinbach G; Henne-Bruns D; Wuerl P
    Nephron Clin Pract; 2009; 111(2):c102-9. PubMed ID: 19142022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A high body mass index and female gender are associated with an increased risk of nodular hyperplasia of parathyroid glands in chronic uraemia.
    Basile C; Lomonte C; Vernaglione L; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Cazzato F
    Nephrol Dial Transplant; 2006 Apr; 21(4):968-74. PubMed ID: 16326747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of severe metastatic calcification in hemodialysis patients.
    Yeh SM; Hwang SJ; Chen HC
    Hemodial Int; 2009 Apr; 13(2):163-7. PubMed ID: 19432688
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Female hemodialysis patients have an increased risk of nodular hyperplasia of parathyroid glands.
    Lomonte C; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
    J Nephrol; 2005; 18(1):92-5. PubMed ID: 15772929
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pharmacotherapy and interventional treatments for secondary hyperparathyroidism: current therapy and future challenges.
    Komaba H; Shiizaki K; Fukagawa M
    Expert Opin Biol Ther; 2010 Dec; 10(12):1729-42. PubMed ID: 21058933
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Secondary hyperparathyroidism: incidence, clinical presentations, treatment].
    Samokhvalova NA; Romanchishen AF; Gerasimchuk RP; Grinev KM; Zemchenkov AIu
    Vestn Khir Im I I Grek; 2007; 166(5):78-81. PubMed ID: 18154100
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical experience with percutaneous ethanol injection therapy in hemodialysis patients with renal hyperparathyroidism.
    Nakamura M; Fuchinoue S; Teraoka S
    Am J Kidney Dis; 2003 Oct; 42(4):739-45. PubMed ID: 14520624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fracture risk after parathyroidectomy among chronic hemodialysis patients.
    Rudser KD; de Boer IH; Dooley A; Young B; Kestenbaum B
    J Am Soc Nephrol; 2007 Aug; 18(8):2401-7. PubMed ID: 17634437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Hyperparathyroidism in urology].
    Koide T
    Clin Calcium; 2005 Dec; 15(12):73-8. PubMed ID: 16322677
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Percutaneous ethanol injection therapy for advanced renal hyperparathyroidism in Japan: 2004 survey by the Japanese Society for Parathyroid Intervention.
    Kakuta T; Fukagawa M; Kitaoka M; Koiwa F; Onoda N; Tominaga Y; Akizawa T; Kurokawa K;
    NDT Plus; 2008 Aug; 1(Suppl 3):iii21-iii25. PubMed ID: 25983968
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtotal parathyroidectomy: a possible treatment for calciphylaxis.
    Bahar G; Mimouni D; Feinmesser M; David M; Popovzer A; Feinmesser R
    Ear Nose Throat J; 2003 May; 82(5):390-3. PubMed ID: 12789768
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of subtotal parathyroidectomy in patients on haemodialysis].
    Vujić D; Majster Z; Lazić N; Radmirović A; Kekić Z
    Srp Arh Celok Lek; 1994; 122(1-2):34-7. PubMed ID: 17972801
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Secondary hyperparathyroidism].
    Imanishi Y; Inaba M
    Nihon Rinsho; 2006 Jun; Suppl 2():31-6. PubMed ID: 16817344
    [No Abstract]   [Full Text] [Related]  

  • 54. [Sclerotization of the parathyroid glands--description of a method].
    Brzac HT; Pavlović D; Halbauer M; Bence-Zigman Z; Molnar V
    Lijec Vjesn; 1989 Dec; 111(12):463-5. PubMed ID: 2699908
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognosis of parathyroid function after minimally invasive radioguided parathyroidectomy (MIRP) and percutaneous ethanol injection therapy (PEIT) for primary hyperparathyroidism.
    Kakuta T; Suzuki Y; Tadaki F; Uemura K; Tanaka R; Tanaka S; Kubota M; Sakai H; Kurokawa K; Saito A
    Biomed Pharmacother; 2002; 56 Suppl 1():41s-47s. PubMed ID: 12487250
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Parathyroid graft function after presternal subcutaneous autotransplantation for renal hyperparathyroidism.
    Echenique-Elizondo M; Díaz-Aguirregoitia FJ; Amondarain JA; Vidaur F
    Arch Surg; 2006 Jan; 141(1):33-8. PubMed ID: 16415409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients.
    Kitaoka M; Fukagawa M; Ogata E; Kurokawa K
    Kidney Int; 1994 Oct; 46(4):1110-7. PubMed ID: 7861705
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Significance of point of no return in therapeutic strategy for treatment of renal osteodystrophy; from histopathological findings].
    Koiwa F; Hirose M
    Clin Calcium; 2004 Sep; 14(9):46-52. PubMed ID: 15577109
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.
    Saunders RN; Karoo R; Metcalfe MS; Nicholson ML
    Postgrad Med J; 2005 Apr; 81(954):255-8. PubMed ID: 15811891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ten years' experience in subtotal parathyroidectomy of hemodialysis patients.
    Jovanovic DB; Pejanovic S; Vukovic L; Djukanovic L; Jankovic R; Kalezic N; Paunovic I; Zivaljevic V
    Ren Fail; 2005; 27(1):19-24. PubMed ID: 15717630
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.